Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/26505
Title: | Development of a national EUCAST challenge panel for antimicrobial susceptibility testing | Authors: | Desmet, S. Verhaegen, J. Glupzcynski, Y. VAN ELDERE, Johan Melin, P. Goossens, H. Pierard, D. Declercq, P. Lagrou, K. Boel, A. Cartuyvels, R. Denis, O. Vandewal, W. Saegeman, V. |
Issue Date: | 2016 | Source: | CLINICAL MICROBIOLOGY AND INFECTION, 22(8), p. 704-710 | Abstract: | A challenge panel of bacterial strains useful for clinical laboratories to validate their European Committee on Antimicrobial Susceptibility Testing (EUCAST) antimicrobial susceptibility test (AST) system was established. A total of 117 strains, obtained from Belgian Reference Centres (n = 57) and from routine clinical samples (n = 60) was selected based on resistance pattern. These strains were analysed in seven different laboratories by three different automated AST systems (Vitek (n = 2), Phoenix (n = 2) and Microscan (n = 2)) and by disc diffusion from five different manufacturers (Rosco (n = 2), Becton-Dickinson (n = 2), Biomerieux (n = 1), Bio-rad (n = 1) and i2a (n = 1)). To select the challenge panel, selection criteria were set for categorical agreement between the different systems and the number of very major errors, major errors and minor errors. Very major and major errors for at least two antibiotics were observed in 43% of all strains, leading to the exclusion of these strains from the selected panel. In only 10% of all tested strains was there 100% categorical agreement for all antibiotics. Finally, 28 strains (14 Gram-positive and 14 Gram-negative) covering a wide spectrum of resistance mechanisms were selected. Pilot-testing of this challenge panel in 20 laboratories mainly confirmed the results of the validation study. Only six strains withheld for the pilot study could not be used as challenge strain due to an overall (very) major error rate of >5% for a particular antibiotic (n = 5) or for two antibiotics (n = 1). To conclude, this challenge panel should facilitate the implementation and use of EUCAST breakpoints in laboratories. S. Desmet, (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. | Document URI: | http://hdl.handle.net/1942/26505 | ISSN: | 1198-743X | e-ISSN: | 1469-0691 | DOI: | 10.1016/j.cmi.2016.05.011 | ISI #: | 000383824200011 | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Goosens.pdf | Peer-reviewed author version | 525.38 kB | Adobe PDF | View/Open |
Desmet.pdf Restricted Access | Published version | 241.51 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
3
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
10
checked on Sep 21, 2024
Page view(s)
54
checked on Jul 20, 2022
Download(s)
96
checked on Jul 20, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.